BSCAX
Price
$23.87
Change
-$0.05 (-0.21%)
Updated
Jul 13 closing price
Net Assets
639.81M
VSCAX
Price
$31.93
Change
-$0.39 (-1.21%)
Updated
Jul 13 closing price
Net Assets
11.34B
Interact to see
Advertisement

BSCAX vs VSCAX

BSCAX vs VSCAX Comparison Chart in %
View a ticker or compare two or three
VS
BSCAX vs. VSCAX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSCAX is a Buy and VSCAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCAX has more cash in the bank: 11.3B vs. BSCAX (640M). BSCAX pays higher dividends than VSCAX: BSCAX (0.39) vs VSCAX (0.19). BSCAX was incepted earlier than VSCAX: BSCAX (9 years) vs VSCAX (27 years). BSCAX (1.21) is less costly to investors than VSCAX (1.10). VSCAX is a more actively managed with annual turnover of: 79.00 vs. BSCAX (30.28). BSCAX (6%) and VSCAX (6%) have equivalent initial investment costs. VSCAX has a lower initial minimum investment than BSCAX: VSCAX (1000) vs BSCAX (2500). VSCAX (34.73) and BSCAX (33.82) have marching annual gain over last year. BSCAX return over 5 years is better than : 93.81 vs. VSCAX (61.75).
BSCAXVSCAXBSCAX / VSCAX
Total Expense Ratio1.161.10105%
Annual Report Gross Expense Ratio1.211.10110%
Fund Existence9 years27 years-
Gain YTD21.43127.69777%
Front Load6%6%105%
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets640M11.3B6%
Annual Yield % from dividends0.390.19206%
Returns for 1 year33.8234.7397%
Returns for 3 years85.5071.94119%
Returns for 5 years93.8161.75152%
Returns for 10 yearsN/A104.00-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IJMSX15.77N/A
N/A
VY® JPMorgan Mid Cap Value S
RSNYX67.09N/A
N/A
Victory Global Energy Transition Y
IUERX32.35N/A
N/A
JPMorgan International Focus R2
AFOCX25.98N/A
N/A
Archer Focus
JNGLX88.37-0.69
-0.77%
Janus Henderson Global Life Sciences D